Authors:
Doren, M
Rubig, A
Bennink, HJTC
Holzgreve, W
Citation: M. Doren et al., Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetatereplacement therapy, FERT STERIL, 75(3), 2001, pp. 554-559
Citation: M. Doren et G. Samsioe, Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995, HUM REP UPD, 6(5), 2000, pp. 419-426
Authors:
Link, TM
Doren, M
Lewing, C
Meier, N
Heinecke, A
Rummeny, E
Citation: Tm. Link et al., Cross-sectional area of lumbar vertebrae in peri- and postmenopausal patients with and without osteoporosis, OSTEOPOR IN, 11(4), 2000, pp. 304-309
Citation: M. Doren, Management of hormone replacement therapy and selective estrogen receptor modulators (SERMs) in women with systemic hepatic, renal, or bone disease -Individual hormone therapy, GYNAKOLOGE, 33(9), 2000, pp. 645-651
Authors:
Doren, M
Rubig, A
Bennink, HJTC
Holzgreve, W
Citation: M. Doren et al., Resistance of pelvic arteries and plasma lipids in postmenopausal women: Comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy, AM J OBST G, 183(3), 2000, pp. 575-582
Authors:
Doren, M
Rubig, A
Bennink, HJTC
Holzgreve, W
Citation: M. Doren et al., Impact on uterine bleeding and endometrial thickness: Tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy, MENOPAUSE, 6(4), 1999, pp. 299-306
Citation: M. Doren et al., Prenatal diagnosis and obstetric management of Larsen's syndrome in a patient with an unrecognized family history of the disease, GYNECOL OBS, 46(4), 1998, pp. 274-278